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Abstract 
Cancer cell lines represent an indispensable resource in the research of tumor biology. 
It has always been assumed that the genomic properties contained in the primary 
tumor specimen are maintained in their corresponding cell lines, but do they really 
mirror each other? 
In this study, we investigated the effects of prolonged in-vitro culture on 13 in-house 
established HCC cell lines at early passages and established passages. The cell lines 
were divided into 3 different stages, namely the parental (pO-p5), early passages 
(pl5-p30) and established cell line (p50-p60), were studied by an integrative analysis 
of molecular cytogenetics (Comparative Genomic Hybridization and Spectral 
Karyotyping), expression profiling and functional studies. 
Unsupervised clustering of CGH results showed 11 out of 13 cell lines (85%) 
displaying similar chromosomal gains and losses throughout the three stages. 
Common HCC related aberrations such as +Iql2-q31, -4ql2-q35, -8p 12-23 and -
13ql2-q21 were found to be maintained despite prolonged culture. With SKY 
analysis, the ploidy status as well as some stem-line aberrations was maintained over 
the passages. On the other hand, some translocation events were lost while a number 
of de novo translocations occurred in the later passages. 
ii 
Global transcriptional changes of 8 pairs of parental HCC and their corresponding 
early passages were studied by microarray profiling. It was remarkable to find that 
the parental tumors and their corresponding early passages could be categorized into 
two distinct dendrograms from unsupervised hierarchical clustering. The underlying 
differential-expressed genes were mostly those derived from the metabolic pathways 
including lipid metabolisms and glycolysis that are crucial for tumor 
microenvironment adaptations. Deregulated gene expressions participated in these 
metabolic pathways may have caused the cultured cells towards higher drug 
tolerance. 
Nevertheless, the expression of a number of genes was maintained between the 
parental and corresponding sub-culture. Bioinformatic analysis suggested many 
cancer-associated genes such as ATF5, VTN, CLU and DUSPl that are involved in 
the TNF-Alpha, TGF-Beta, Mapkinase and Cyclin D1 signaling pathways were 
maintained in the passaged HCC cultures. In addition, there was no significant 
alteration on the cell morphology and growth kinetics of the early passage as 
compared to the established passage. In conclusion, our in-housed established HCC 
cell lines can be used as reliable in-vitro study models as many cancerous properties 









胞遺傳學（比較基因組雜交和光譜核型）（Comparative Genomic Hybridization 
and Spectral Karyotyping),基因表達譜（Expression prof i l ing)和功能性研究的 
方法來對這些細胞進行一個綜合分析。 
無監督聚類的比較基因組雜交結果顯示 1 1 / 1 3的細胞系（ 8 5 % )在所劃分的 
三個主要階段中，顯示出相似的細胞基因之染色體之增減變化。長期培養的細 
胞係仍有保留著常見的肝細胞癌相關畸變如+Iql2-q31，-4ql2-q35, -8pl2-23和-











學分析表明許多癌症相關基因，如參與TNF-Alpha’ TGF-Beta, Mapkinase,和 
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Chapter 1 - Introduction 
1.1 Incidence 
Hepatocellular carcinoma (HCC) is a highly aggressive tumor that belongs to the 
most common type of liver cancer. It is the fifth most common cancer world-wide 
represented by 85% of all liver cancer cases (Parkin et aL, 2001). In male, HCC 
ranks fifth among the most common cancer and with third highest cancer-related 
mortality rate (Figure 1.1 and Figure 1.2). As for females, it is the eighth most 
common cancer and ranks sixth in mortality rate (Figure 1.3 and Figure 1.4). HCC is 
more prevalent in males than females, with the ratio of 4:1 (World Health 
Organisation). The approximate incidence to mortality ratio accounted for HCC in 
Hong Kong is approximately 1:1 (0.81 in male and 0.93 in female) (Hong Kong 
Cancer Registry 2006). 
Regions that are highly affected by HCC include Southeast Asia, China and Sub-
saharan Africa. As for the Western countries, HCC has been reported in North 
America and Western Europe (Figures 1.5a and 1.5b). In Hong Kong, liver cancer 
ranks the third highest incidence for male population and fifth for female population 
between years 2001-2005 (Figure 1.6). 
The poor prognosis of HCC is largely attributed to most tumors not being diagnosed 
in time for intervention. By the time of clinical presentation, most patients are at the 
advanced stages with intra- and extra-hepatic metastases, often with poor underlying 
liver function as well. In terms of remedy, surgical resection remains the most 
effective treatment for patients with HCC. However, recurrences of this disease after 
surgical resection are common (Hung et al., 2008). 
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Figure 1.3: New cancer cases in all ages for female worldwide estimated in year 2002. 
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Figure 1.4: Mortality rates in all ages for female worldwide estimated in year 2002. 
Figure adapted from Ferlay et al. 2004 
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Figure 1.5a: Liver，Males. Age-Standardized incidence rate per 100,000 populations 
Figure adapted from Ferlay et al. 2004 
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Figure 1.5b: Liver, Females. Age-Standardized incidence rate per 100,000 populations. 
Figure adapted from Ferlay et al. 2004 
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Figure 1.6: Incidence Rates of Five Leading Causes of Cancer by Sex 2001-2005 sites 
in Hong Kong in year 2006/2007. 
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1.2 Etiological Factors 
The most recognized risk factors involved in HCC development are chronic hepatitis 
B and C viral infection, liver cirrhosis, chronic alcohol consumption and dietary 
aflatoxin Bl . Recently, obesity has been recognized as another important pre-
disposing factor in the development of HCC. 
1.2.1 Viral Hepatitis Infection 
Hepatocarcinogenesis is strongly influenced by the infection of hepatitis B (HBV) 
and C (HCV) viruses. It is reported that 2 billion individuals of the world's 
population are currently infected by HBV and the mortality rate caused by this 
infection has been estimated to be 320,000 cases per annum (Paraskevi et al., 2006). 
In HCC，about 30-50% of the cases are associated with HBV infection (Lavanchy et 
al., 2004). HBV infection is prevalent in countries with high endemic for HCC such 
as Sub-saharan Africa and China as well as other developing countries (Figure 1.7). 
As for HCV, it infects about 170 million individuals throughout the world (Chisari et 
al, 2005; Cohen et al, 1999). About 0.4-2.5% of HCC was found to be affected by 
HCV (Colombo M. 1999). HCV infection is estimated to increase the risk for HCC 
development up to 17-fold (Donato et aL, 1998). Both HBV and HCV infection can 
be detected through the elevated levels of serum HBsAg and anti-HCV in patients 
(Figure 1.8). 
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Figure 1.7: Geographic distribution of chronic Hepatitis B virus infection. 
Source: CDC. Travellers" health: yellow book. Atlanta. GA; US Department of Health and 
Human Services. CDC. 2008. Available at http://wwwn.cdc.izov/travel/vellowbookch4-
HepB.aspx 
8 
Chapter 1 - Introduction 
HBsAg (%) Anti-HCV (%) 
Melanesiai7.9 
Western Africa 12.3 2.2 
Middle Africa 12.2 6.4 
East Asia (other) 12.1 
China 12.0 [ ^ ^ ^ S H I 3.0 
Eastern Africa 11.3 驢 麵 1.7 
Micro/Polynesia 9.3 0-7 
South-EastAsia 9.1 | …. . J g 1 
Southern Africa 8.6 1.6 
Northern Africa 5.4 8.2 
Western Africa 4.9 ^ j ^ i . s 
South Central Asia 3.5 3.5 
Caribbean 2.9 E l U 1 7 
Eastern Europe 2.8 ^ § 1 . 8 
Southern Europe 2.8 0.7 
Japan 2.0 Q g j 2.3 
South America 1.7 i ^ l 2.0 
Central America 1.2 國 0.6 
Australia/New Zealand 0.6 g 0.3 
Western Europe 0.5 j 0.5 
Northern Europe 0.5 • 
Northern America 0-5 p i 1-6 
20 15 10 5 0 5 10 15 20 
Population prevalence (%) 
Figure 1.8: Prevalence of chronic infection by hepatitis B (carriers of HBsAg) 
and hepatitis C (seropositivity for anti-HCV) by World Areas. 
Source: Adapted from Parkin et al.，2006. 
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1.2.1.1 Hepatitis B Virus 
Among all related etiologic agents, HBV infection demonstrated the strongest 
association with HCC. HBV is a member of Hepadnaviridae family, with 3.2 kilo-
base viral genome being packaged in an envelope that contains hepatitis B surface 
antigen (HBsAg). The HB viral genome is responsible for the production of viral 
proteins such as a reverse transcriptase/DNA polymerase (pol), hepatitis B core 
antigen (HBcAg), L, M, and S envelop proteins and transactivating protein (HBx) 
which are essential for the virus life cycle. 
One of the mechanisms for HBV induced HCC is believed to be the integration of 
HBV into the host cells, which has been proposed to cause the host genome to 
become unstable and susceptible to multiple chromosomal rearrangements. This 
direct oncogenic effect of HBV integrants on hepatic carcinogenesis has been 
suggested based on the fact that >80% of HBV-related HCC tumors harbor one or 
more integrations of HBV DNA into the host chromosomes (El-Serag et al., 1999). 
Hepatocyte transformation may have been directly influenced by the viral interaction 
with transformation-associated genes close to or within the insertional site. 
On the other hand, long lasting viral multiplications and expression of HBV proteins 
are known to stimulate the host immune response, leading to liver inflammation, 
cirrhosis and ultimately cancer. The reaction of body immune system towards viral 
infections can also lead to the constant stimulation of DNA repair processes. Any 
complication or defect of this process may well contribute to the progression of 
hepatocarcinogenesis (Kremsdorf et al.’ 2006; Buendia MA 1992; El-Serag et al” 
1999). 
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It is known that HBx can promote HCC tumorigenesis by up-regulating potent 
angiogenic factor vascular endothelial growth factor transcription or stabilizing the 
hypoxia inducible factor HIF-1 (Lee et al., 2000; Yoo et al” 2003, 2004; Moon et al” 
2004). Furthermore, up-regulation of cytoplasmic beta-catenin by Hbx can lead to 
the activation of Wnt/beta signalling pathways (Cha et al., 2004; Ding et al., 2005). 
Thus, induction of all these important pathways by HBx can promote rapid cell 
proliferation, migration and invasion that underlie the development of HCC 
(Andrisani et al., 1999; Brechot et al., 2000; Feitelson et al” 1999; Idilman et al., 
1998; Moradpour et al, 2003; Poussin et al, 1999；. 
1.2.1.2 Hepatitis C Virus 
HCV is an RNA virus that belongs to flaviviridae family (van Regenmortel et al, 
2000). It has 9.6kb long positive-stranded RNA genome which encodes four 
structural proteins (C, El , E2, and p7) and six non-structural proteins (NS2-NS5B) 
(Szabo et aL, 2003). 
Unlike HBV, HCV does not integrate into its host genome and has a predominantly 
cytoplasmic life cycle. Hence, HCV is thought to involve in indirect mechanisms 
such as chronic inflammation, steatosis, fibrosis, oxidative stress and pathological 
effects in the induction of hepatocarcinogenesis (Tornillo et al., 2000). 
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HCV proteins were found to confer oncogenic effects by up-regulating mitogenic 
processes leading to rapid cell proliferation. High rate cell proliferation under 
oxidative stress can result in DNA damages, whereby initiating the malignant 
transformation of hepatocyte (Bartosch et al., 2009). HCV core proteins have also 
been reported to modulate the transcription activity of NFKB and STAT-3 (Waris et al., 
2003). Other host's signaling pathways that have been reported to be influenced by 
HCV proteins include Wnt/b-catenin and TGF-jS. The mechanisms involved in the 
progression of HCC and chronic liver disease induced by HBV and HCV infections 
are displayed in Figure 1.9. 
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Figure 1.9: Mechanisms involved in HBV- and HCV-related chronic liver disease 
and HCC. 
Different viral proteins encoded by these two viruses have similar influences on the 
immune response, cell cycle regulations as well as causation of genetic aberrations in the 
cells. Source: Adapted from Szabo et al., 2004. 
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1.2.2 Cirrhosis and Chronic Inflammation 
Liver cirrhosis can arise from chronic hepatocellular necrosis, inflammation and 
fibrosis. Diffused, interlacing septal fibrosis and nodules of regenerating hepatocytes 
are the common features of a cirrhotic liver. In Hong Kong, patients with chronic 
liver disease and cirrhosis are about 364 cases per annum (Figure 1.10). 
Etiologic factors that predispose to liver cirrhosis include excessive alcoholic intake 
and viral infection. It is suggested that there might be complex interactions between 
alcoholics and infection with HBV or HCV contributing to liver cirrhosis which in 
turn progress to HCC (Donate et al, 2002; Hassan et aL, 2002; Morgan et cd., 2004; 
Hiroaki et aL, 2007). 
About 80-90% of HCC patients are presented with underlying hepatic cirrhosis. 
Therefore, cirrhosis is often regarded as the premalignant stage of HCC. However, 
not all HCC cases are related to cirrhosis and chronic inflammation as some HCC 
can arise from a non-cirrhotic liver background. 
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Figure 1.10: Ten Leading Causes Deaths sites in Hong Kong in year 2006. 
Information obtained from The Hong Kong Cancer Registry, Hospital Authority. 
The total number of chronic liver disease and cirrhosis detected among Hong 
Kong populations per annum is indicated in red box. 
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1.2.3 Dietary Aflatoxin Contamination 
Aspergillus flavus is responsible for aflatoxin production. Aflatoxin is a carcinogen 
which aids the carcinogenesis of hepatocellular cancer. Improper storage of food 
such as com, peanuts, and grains under intense heat and excessive humidity 
condition can cause aflatoxin production. 
Bioactivation of aflatoxin B1 by cytochrome p450 monooxygenases resulted in the 
formation of reactive electrophile and aflatoxin -8, -9 epoxide (Essigmann et al., 
1982; Shimada et al, 1989; Aoyama et aL, 1990). These particles can bind to 
guanine residues through covalent bond. HCC tumors induced from Aflatoxin B1 
have been shown to harbor a p53 hotspot point mutation in codon 249 (AGG to AGT, 
arginine to serine). The characteristic genetic change associated with aflatoxin B1 
affects the p53 gene, which is a critical tumor suppressive gene in human cancers 
(Ozturk et al.’ 1991; Lasky et al,, 1997; Deng et al., 1998). 
1.2.4 Obesity 
Obesity has been statistically proved to be a significant independent risk factor for 
HCC in both alcoholic cirrhosis and cryptogenic cirrhosis patients, probably due to 
the existence of antecedent steatosis (Polesel et aL, 2009; Stephen et ah, 2004; Ohki 
et al., 2008; Wolk et al., 2001). It has been reported that alcohol, tobacco and obesity 
can interact synergistically to increase the risk of HCC (Marrero et al., 2005). 
However, obesity alone does not serve as a risk factor in hepatitis C or chronic 
hepatitis B infected patients. 
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1.3 Genomic Aberrations of HCC 
1.3.1 Chromosomal Imbalances 
A wide spectrum of genomic abnormalities has been characterized extensively in 
HCC using various molecular approaches such as conventional comparative genomic 
hybridization (CGH), array-CGH and microsatellite analysis. In HCC, recurrent 
chromosomal gains have been defined on Iq (58-86%), 8q (48-77%), 17q (22-46%) 
and 20q (5-37%), whereas frequent allelic losses were detected on 4q (32-70%), 8p 
(29-77%), 13q (16-37%), 16q (30-70%) and 17p (10-52%) (Guan et al, 2000; Chang 
et cd., 2002; Lau and Guan 2005; Marchio et al, 1997; Wong et al, 1999; Kusano et 
al” 1999; Crawley and Purge 2002; Nishimura et al., 2006; Zondervan et al., 2000; 
Nose et al., 1993; Takahashi et al, 1993; Fujimoto et al, 1994; Fujiwara et al, 1994; 
Yeh et al, 1994，1996; Yumoto et al, 1995; Nagai et al., 1997). LOH of 4q，13q, and 
16q have been further shown to be associated with poorly differentiated HCC tumors, 
vascular invasion, and intra-hepatic metastasis (Okabe et al, 2000). 
To further elucidate the aberrant genomic loci for underlying oncogenes and tumor 
suppressor genes, efforts to define the critical smallest overlapping regions (SOR) 
have been conducted. The SORs mapped in HCC, include Iql2-q22, 7q21-q31, 
8p21-p22, 8q22-q24, 17pl3, 17q21-q25 and 20ql2-ql3 (Marchio et al., 1997; Wong 
et al., 1999; Kusano et aL, 1999; Kuroki et al., 1995a and 1995b; Nishimura et al., 
2002; Okabe et al, 2000). Recent informatic analysis on the genomic data further 
highlighted gains of Iq21-q22 and 8q21-q24, and allelic losses on 8p21-p23, 13ql2-
ql4 and 17pl3 as causal molecular events in the HCC tumorigenesis (Poon et al； 
2006; Hertz et al” 2008). 
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1.3.2 Candidate Tumor Suppressor Genes and Oncogenes in HCC 
1.3.2.1 Chr. Iq21-q22 gain 
The gain of Iq was also frequently associated with a regional amplification of lq21-
q22. Whilst the presence of one or more proto-oncogene has been proposed to this 
region, positional mapping from our group has refined this site to three affected loci, 
in which over-expression of candidate genes including JTB’ SHCl, CCT3 and COFA 
was indicated (Wong et al., 2003). 
Recent study by Guan XY and co-workers isolated a candidate proto-oncogene, 
Amplified in Liver Cancer 1 (ALCl), from lq21 by hybrid selection. They 
demonstrated that ALCJ was frequently amplified and overexpressed in HCC. 
Functionally, y4LC7-transfected cells possessed a strong oncogenic ability, increased 
in the colony formation in soft agar and tumorigenicity in nude mice. They further 
demonstrated that overexpression of ALCl could promote Gl/S phase transition and 
inhibit apoptosis (Ma et al., 2008). 
1.3.2.2 Chr. 8p21-p23 loss and 8q21-q24 gain 
Frequent 8q gain with concurrent loss of 8p has been reported in HCC tumors with 
minimal degree of aberrant chromosomes, suggesting a role for these alterations in 
the early liver carcinogenesis (Nishimura et al., 2002). Two SOR of high-level gains 
at 8q21 and 8q24 have also been defined. 
Whilst genomic DNA amplifications are often considered to play a role in tumor 
progression, the finding of the same chromosome arms abnormalities in early HCC 
may be interpreted as the extent of genomic gains at these sites have increased with 
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tumor evolution. Transcription regulatory oncoproteins on chromosome 8q, c-Myc 
(8q24) and E2F5 (8q21), could have promoted hepatic transformation via the 
uncontrolled cell proliferation, stimulation of mitogenic signaling and consequently 
oncogenesis (Polanowska et aL, 2000). 
The incidence of 8p deletion was shown to increase in the advanced clinical stages, 
increased tumor size and metastatic behavior of HCC tumors (Qin et al., 1999; 
Fujiwara et al., 1995). Microsatellite studies on 8p have suggested three distinct 
regions of allelic loss at 8p21, 8p22 and 8p23 (Pineau et al., 1999), and pointed to 
the existence of several putative tumor suppressor genes, including DLC-1 (8p21.3-
p22), FEZl (8p22) and LPTS (8p23), all of which could affect the biologic behavior 
of hepatocytes by altering cell cycle control, growth inhibition and tumorigenicity. 
1.3.2.3 Chr. 13ql2-ql4 loss 
Early allelic mapping on chr.lSq suggested the existence of 3 SOR deletions, all of 
which might hold inference in the hepatocarcinogenesis (Lin et al, 1999). In 
particular, the sub-chromosomal SOR at 13ql2-ql4 displayed significant 
associations with clinicopathological features, where a relation with advanced stage 
HCC and more aggressive tumor behaviors have been shown (Wong et al., 2002). 
Two well-known tumor-suppressor genes, RBI (at 13ql4) and BRCA2 (at 13ql3), are 
thought to be the likely target genes of the region. However, no strong evidence has 
emerged to support a significant role of BRCA2 in the induction of liver 
tumorigenicity (Rider et al., 2002). Moreover, the lack of evidence for genetic 
alterations in RBI in HCC suggested the possible involvement of other mechanism(s) 
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in the disruption of the gene expression. In fact, it is becoming apparent that RBI is 
mainly inactivated in HCC by ubiquitin degradation at the protein level 
consequential from binding to a liver oncoprotein Gankyrin, which is a component of 
the 26S proteasome (Higashitsuji et al,, 2000). 
Recent discovery of DLC2 (on 13ql2.3) although has been shown to induce a growth 
suppressive function in-vitro, was only under-expressed in 18% of human HCC 
tumors (Ching et aL, 2003). These reports would invariably suggest that the bona 
fide tumor suppressor gene(s) resultant from the genomic losses of 13ql2-ql4 
remained to be discovered in HCC. 
1.3.2.4 Chr. 17pl3 loss 
Frequent LOH at 17p in HCC has been described in relation to increasing tumor size, 
poorly differentiated tumors and a prognostic risk for tumor recurrence following 
surgery (Kusano et al,, 1999; Kuroki et al, 1995b; Konishi et al, 1993). 
The p53 gene located at 17pl3.1 is hitherto the consistent tumor suppressor gene 
implicated in liver carcinogenesis (Puisieux et aL, 1997). Among the many 
properties of p53, its role in preventing DNA replication in aberrant cells could have 
been abrogated by deletion and/or mutations, thus contributing importantly to genetic 
instability and tumor progression. Mutations of p53 gene have been suggested to 
occur preferentially in undifferentiated HCCs and in coalesce with the loss of another 
p53 allele in late stage tumors (Oda et al., 1992). 
20 
Chapter 1 - Introduction 
1.3.3 Chromosomal Rearrangement 
The current paucity on translocation information of HCC reflects the difficulties in 
culturing malignant hepatocytes in-vitro. The frequent poor chromosome 
morphology obtained has also precluded accurate analysis. By refining the tissue 
culture conditions and deploying Spectral Karyotyping (SKY), our group had 
reported on the chromosomal rearrangements in primary HCC tumors. Frequent 
structural abnormalities were found on chromosomes 1, 8, 17 and 19. In particular, 
the chromosome regions Ipl3-q21, 8pl2-q21, 17pll-ql2, 17q22 and 19pl0-ql3.1 
were involved in multiple rearrangements (Wong et al., 2000). 
Earlier G-band karyotypes on HCC tumors have also reported on the frequent 
unbalanced translocations of chromosome 1 with structural abnormalities suggested 
to affect bands lpl3, lp22, lp32, lp34，and lp36 (Yeh et al, 1994; Parada et al., 
1998). 
More recently, using region-specific multiplex-FISH probes, Tjia and colleagues 
have (Tjia et cd., 2007) defined structural aberrations on chromosomes 4q, 13q and 
16q in six HCC cell lines. Common breakpoints on 4q were suggested at 4q21-22 
and 4q27-31，where inactivation of candidate tumour suppressor gene Rho-GTPase 
activating protein 10 (ARHGAP10; located on 4q31.2) has been proposed from the 
rearrangements. ARHGAP 10 serves as negative regulators of Rho-GTPase signaling 
pathways that are involved in actin cytoskeleton dynamics, cell proliferation, and 
differentiation (Aznar et al., 2001). 
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1.4 Cell Lines as In-vitro Study Models 
Cell lines derived from primary cancer tumors represent one of the most vital 
resources for cancer research. As biomedical models, they have allowed investigators 
to have an unlimited supply of cells with similar genotypes and phenotypes. Cell 
lines have been used to portray complex biological systems and specific genomic 
aberrations that are believed to be representative of its primary tumors. Thus, it has 
been assumed that established cell lines posses similar genomic alterations detected 
in the primary specimens and they emulate the biological effects that are observed in 
the originated tumors (Wistuba et aL, 1998; Wistuba et aL, 1999). 
The benefits gained from culturing cell lines however have some drawbacks. Cell 
lines are cultured in a much simpler environment than the originated tumors, which 
are in a much complicated surrounding. Thus, the change of tumor 
microenvironment might alter the characteristics of propagated cell lines (Li et aL, 
2008; Ishii et al” 1999; Schmidt et al., 1999). 
In addition, since cell lines grow at a rapid speed, the genomic expressions that are 
involved in proliferation may deviate from its primary cells (Perou et al., 1999; Ross 
et al.’ 2000). Besides, the course of establishing conventional cell lines might trigger 
permanent transformation of biological properties, such as gain or loss of copy 
number, the ability to migrate and metastasize, signaling pathways and cell 
morphology that were unrelated to the cancerous tumor. Hence despite their values, 
the reliability of these cancer models remains a dispute. However, there have been 
minimal studies dedicated to the investigations on the genomic resemblance and gene 
expressions in cell lines and their originated primary tumor. 
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1.5 Aim of study 
Cell lines derived from human tumors have historically served as the primary 
experimental model system for exploration of tumor cell biology and pharmacology. 
However, it is also well recognized that in-vitro culture conditions can give rise to 
additional chromosomal aberrations and altered gene expressions. Information on 
culture associated genomic changes and biological behaviors, on the other hand, have 
been minimal to date. 
In this study, a systematic investigation into the genomic alterations and functional 
properties of HCC cell lines and their parental tumors was carried out. Thirteen in-
housed established HCC cell lines {HKCI series of cell lines) were characterized for 
their genomic events at the parental (PO-5), early passages (PI5-30) and established 
passages (P50-60). 
In this respect, molecular cytogenetic analysis for genomic imbalances and structural 
rearrangements was performed by conventional Comparative Genomic Hybridization 
(CGH) and Spectral Karyotyping (SKY), respectively. With the aid of cDNA 
microarray, expression profile of parental tumors and cell lines was achieved at the 
transcriptional level. The growth kinetics and drug sensitivity to doxorubicin, which 
is a first-line chemotherapeutic agent for the treatment of HCC, were also assessed. 
This study aims to provide a better understanding on the value and limitations of 
HCC cell lines. 
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1.5.1 Objectives 
1) To investigate how well the genomic and transcriptomic properties of primary 
tumors are represented in their corresponding cell lines. 
2) To discover the disparities, if any, that occurs between primary HCC tumor 
and the propagated cell line. 
24 
Chapter 2 - Materials and Methods 
CHAPTER TWO 
MATERIALS AND METHODS 
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2.1 Materials 
Reagents/ Buffers Company/Recipe 
Ikb Plus DNA Ladder Gibco Invitrogen Corporation 
Carnoy fixative solution Methanol and glacial acid in the ratio of 3:1 
3M sodium chloride, 0.3M sodium citrate, 
20 X SSC solution pH7.0 
4',6-Dianiidino-2-phenylindole (DAPI) Sigma Chemical Company 
Agarose, regular Biowest 
AIM-V Gibco Invitrogen corporation 
,1 
BamHI Amersham Life Sciences 
Biotin-16-dUTP Boehringer Mannheim 
CAD-Antibodies Detection Kit Applied Spectral Imaging ‘ 
Cell Dissociation Buffer Gibco Invitrogen Corporation 
Cy3-dCTP/Cy5-dCTP Amersham Pharmacia Biotech 
Colchicine Sigma Chemical company 
Deoxyribonucleotides(dATP, dCTP, dGTP) Boehringer Mannheim 
Digoxigenin -11 -dUTP Boehringer Mannheim 
Dimethyl sulfoxide (DMSO) Sigma Chemical Company 
Dnase I Boehringer Mannheim �. 
Doxorubicin Pharmadeutical Laboratories 
Ethidium bromide Sigma Chemical Company 
Fetal calf serum (FBS) Gibco Invitrogen corporation 
Formamide Intergen Company 
Goat anti-rabbit IgG antibody Sigma Chemical Company 
Humam Cot-1 DNA Gibco Invitrogen corporation 
Insulin-Transferrin-Selenium Gibco Invitrogen corporation 
Isopropanol BDH Prolabo, VWR International 
L-Glutamine 200mM (lOOX) Gibco Invitrogen Corporation 
Marvel Chivers Ireland Ltd. 
Nuclease free water Sigm Aldrich Company 
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Penicillin and streptomycin Gibco Invitrogen corporation 
Pepsin Boehringer Mannheim 
Phosphate buffer saline (PBS), pH7.4 Sigma Chemical Company 
Phytohaematoaglutinin Gibco Invitrogen Corporation 
Reverse Transcriptase Applied Biosystem 
Proteinase K recombinant, PGR grade Roche Diagnostic corporation 
Rnase Boehringer Mannheim 
RPMI1640 Gibco Invitrogen Corporation 
Salmon sperm DNA Sigma Chemical Company 
Sigma H2O Sigma-Aldrich company 
SkyPaint™ DNA kit H-10 for Human 
chromosomes Applied Spectral Imaging 
Sodium chloride (NaCl) Sigma Chemical Company 
Thiazolyl blue tetrazolium bromide (MTT) Sigma Chemical Company 
Tetramethylrhodamine isothiocyanate 
(TRITC) Sigma Chemical Company 
Trizol Gibco Invitrogen Corporation •丨 
Trypan blue Gibco Invitrogen Corporation 
Trypsin BD Labware company 
Tween 20 Sigma Diagnostic 
Vectorshield anti-fade reagent Vecta Labs 
Yeast tRNA Sigma Chemical Company 
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Equipments Company 
Leitz DM RB fluorescence microscope Leica Corporation 
NanoDrop-1000 UV-VIS Spectrophotomer NanoDrop Technolgies 
ScanArray 5000 Scanner GSI Lumonics, Packard Bioscience 
SD200 Spectracube Applied Spectral Imaging 
Multilabel Plate Readers Perkin Elmer Precisely 
Softwares Company/URL 
CGH software version 3.1 on Cytovision Applied Imaging Ltd. 
Eisen 1998 
Cluster Analysis Software http://rana.Ibl.gov/EisenSoftware.htm 
Database for Annotation, Visualization and 
Integration Discovery (DAVID) http://david.abcc.ncifcrf.gov/home.isp 
GenePix Pro 3.0 Packard Biochip Technologies 
Ingenuity Pathway Analysis (IPA) http://www.ingenuitv.com/ 
National Center for Biotechnology 
Information (NCBI) http://www.ncbi.nlm.nih.gov/ 
Prism Software version 3.0 Abacus Concepts Inc., Berkeley, CA 
Significant Analysis for Microarray (SAM) http://www-stat.stanford.edu/~tibs/SAM/ 
Sky View Software version 1.6 Applied Imaging Ltd. 
Eisen 1998 
Tree View Software http://rana.lbl.gov/EisenSoftware.htm 
UCSC Genome Bioinformatics http://www.genome.ucsc.edu/ 
Lab-wares/Tools Company 
Hemacytometer HBG Germany 
Tissue Culture Plate (6-, 12-, 24-,96-well) BD Labware company 
Tissue Culture Flask (10, 25, 75,175 cm2) BD Labware company 
Tissue Culture Dish (100, 150mm) BD Labware company 
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2.2 Cell Lines and Cell Culture 
2.2.1 Cell Lines 
Thirteen in-house established HKCI (Hong Kong Cancer Institute) series of HCC 
cell lines were used as study models (Pang et aL, 2000; Pang et aL, 2002; Wong et al., 
2005; Chan et al., 2005). These cell lines named HKCI-1, HKCI-2, HKCI-3, HKCI-4, 
HKCI-5, HKCI-6, HKCI-7, HKCI-8, HKCI-9, HKCI-10, HKCI-Cl, HKCI-C2, and 
HKCI-C3 were established from the tumorous liver tissue of patients who underwent 
curative surgery for HCC at the Prince of Wales hospital between years 1998-2002. 
In an effort to investigate how representative are cell lines to their corresponding 
parental tumor, each of these cell lines was compared at three stages, namely 
1. Parental (passage 0 - 5 ) , 
2. Early Passage (passage 15-30) and 
3. Established Cell Line (passage 50 - 60). 
2.2.2 Cell Culture 
The HKCI series of cell lines were cultured in AIM-V medium (Gibco Invitrogen 
Corporation) supplemented with 10% fetal bovine serum, 100 lU/ml streptomycin, 
10 ng/ml selenium, 10 |ag/ml transferrin, 10 |ag/ml insulin and 2mM/ml L-Glutamine 
(Invitrogen), Cultures were maintained in a humidified incubator at 37�C in an 
atmosphere of 5% CO2. When culture reached approximately 80% confluent, cells 
were sub-cultured using trypsin/EDTA until the desired passage number is achieved. 
For cytogenetic study, cell growth at 80% confluence was harvested for metaphases 
by colchicine. Cells were then detached by trypsinization and treated with 75 mM 
KCl hypotonic solution for 20 minutes at 37°C. This was followed by fixing in 
Carnoy fixative (acetic acid: methanol, 1:3，v/v). Chromosomes obtained were 
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subjected to Spectral Karyotyping analysis and karyotyped according to the 
International System for Human Cytogenetic Nomenclature (ISCN, 1995). 
2.3 Comparative Genomic Hybridization (CGH) 
High molecular weight DNA was extracted from primary tissue, and from cell pellet 
collected at two passages; PI5-30 and P50-60. CGH was performed as described by 
Wong et a!., 1999. Briefly, tumor and control lymphocytic DNA were differentially 
labeled with biotin-16-dUTP (Boehringer Manheim, Manheim Germany) and DIG-
11-dUTP (Boehringer, Mannheim), respectively, by nick translation. Slides 
containing normal metaphase chromosomes were denatured in 70% formamide /2 X 
SSC (pH 7.0) at 70°C for 1 minute and 30 seconds. The hybridization was performed 
in a humid chamber at 37 for 2 days. Biotin signals were detected through avidin 
conjugated FITC (fluorescein isothiocyanate) antibodies (Sigma, St Louis, MO, 
USA), while DIG-labeled DNA was visualized using antibodies conjugated with 
TRITC (tetramethylrhodamine isothiocyanate) (Sigma). The preparations were 
counterstained with DAPI in antifade solution (Vectashield). 
Hybridized metaphases were captured with a cooled CCD camera mounted on a 
Leitz DM RB (Leica) fluorescence microscope. Three band pass filters (DAPI, FITC, 
and TRITC) were arranged in an automated filter-wheel were employed for image 
acquisition. The CGH software version 3.1 on Cytovision (Applied Imaging Ltd., 
Sunderland, UK) was used for digital image analysis of 8-12 selected metaphases. 
Thresholds for gains and losses were defined as the theoretical value of 1.25 and 0.75, 
respectively. Whole level gain of a whole chromosome arm or amplification of a 
chromosomal region was considered to be present when ratios exceeded 1.5. 
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2.4 Spectral Karyotyping (SKY) 
Twenty-four colours labelled chromosome-painting probes were acquired from 
Applied Spectral Imaging (ASI, Migdal Haemek, Israel). Flow-sorted human 
chromosomes were differentially labelled with spectrum green-dUTP, spectrum 
orange-dUTP，texas red-dUTP, biotin-16-dUTP, digoxigenin (dig)-l 1-dUTP, and a 
combination thereof by degenerate oligonucleotide primed-PCR. Labelled SKY 
probe mixture was applied onto metaphase chromosomes of short-term cultured 
HCC and the propagated HKCI cell line. Hybridisation took place over 3 days in a 
dark humid chamber at 37°C. 
Biotinylated probes were visualised using avidin Cy5 (Amersham Life Sciences, 
Buckinghamshire, UK), and dig-labelled probes by anti-mouse dig antibody (Sigma) 
followed by goat anti-mouse Cy5.5 conjugate (Amersham Life Sciences, 
Buckinghamshire, UK). Chromosomes were counterstained with 4',6-diamidino-2-
phenylindole (DAPI) in anti-fade solution (Vector Shield, Vector Laboratories, 
Burlingame). More than 50 metaphase spreads were examined in HKCI series HCC 
cells and 25 metaphases analysed in the primary tumor. 
Image acquisition was performed using a SD200 Spectracube (Applied Spectral 
Imaging, Ltd., Migdal Haemek, Israel) mounted on a Leica DMRXA microscope 
(Leica, Wetzlar, Germany). Hybridised metaphases were illuminated with a 150W 
xenon lamp and captured through a custom designed optical filter (SKY-1, Chroma 
Technology, Brattleboro, VT). Fourier transformation recovers the spectrum of all 
image points from the interferogram (Schrock, et al’ 1996) and spectral information 
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on each chromosome was analysed by the Sky View 1.6 software (Applied Spectral 
Imaging). 
To define chromosome breakpoints, high quality inverted DAPI images were 
generated by the SkyView software. Assignment of breakpoints were only 
considered when the aberrations were identified in two or more cells, or if the 
observed inverted DAPI banding corresponded to the G-band in other metaphase 
cells. A brief diagram demonstrates the process that involved in Spectral 
Karyotyping is shown in Figure 2.1. 
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Figure 2.1: Schematic representation of the procedures involved in SKY analysis. 
Figure adapted from http://atlasgeiicticsoncologv.om/Deep/ComparCancerCvtogID2QQ 11 .html 
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2.5 Expression Profiling 
Total RNA was extracted from 8 pairs of parental tumors and their corresponding 
early passages (passage 25) using TRIZOL reagent (Invitrogen). Normal liver RNA 
from three individuals was used as a reference pool (Ambion，Austin, TX; Clontech 
Laboratory Inc., Palo Alto, CA; and Strategene, La Jolla, California, USA). The 
expression array experiments were carried out according to the protocol of University 
Health Network Microarray Centre, Toronto, Canada. 
(http://www.microarravs.ca/support/proto.htmn. 
Briefly, 10|ig of total RNA and reference normal liver pool were reverse-transcribed 
with an AncT mRNA primer using Superscript II reverse transcriptase (Invitrogen). 
Following fluorescence labelling of the transcribed cDNA with Cy3-dCTP for test 
(Amersham Pharmacia Biotech) and Cy5-dCTP for reference (Amersham Pharmacia 
Biotech), the cDNAs were combined with calf thymus DNA and yeast tRNA in 
DIGhyb buffer (Roche Diagnostics Corporation, Indianapolis, IN) and hybridised 
onto array slides (19K Human Arrays, UHN Microarray Centre). Hybridisation took 
place in a dark chamber at 37°C for 16 hr, and post-hybridisation washes was carried 
out in lxSCC/0.1%SDS at 50°C for 3 times at 10 min each, and gentle rinsing in 
IxSSC twice for 1-2 min each. The principle of cDNA microarray technique is 
shown in figure 2.2. 
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Hybridized signals were then captured by a laser scanner ScanArray 5000 (GSI 
Lumonics, Packard Bioscience, Pangboume, UK), and the raw images acquired were 
analysed by the GenePix Pro 3.0 (Axon, Union City, CA). Duplicate array 
hybridizations were performed for each test sample. Custom software was employed 
to normalize the Cy3 and Cy5 intensities, and integration of signal ratios determined 
with physical map locations of cDNAs in sequential order of megabase distances 
(http://www.utoronto.ca/cancvto/). The Cy5:Cy3 normalized intensity ratio for each 
EST was subjected to hierarchical clustering by the Cluster software package (Eisen 
1998). After 70% filtering and log transformation, average linkage hierarchical 
clustering was performed. The Treeview software was used for generating the 
graphical visualization of the clustering. 
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Figure 2.2: Principle of cDNA Microarray for Gene Expression. 
This modified figure was adapted from 
(http://userwww.sfsu.edu/~iiifoarts/links/isea2006bioartf/art.bio.isea.06web.html) 
2 samples of RNA, one from tumor and another one from normal cells (control) .cDNAs 
are created from each by reverse-transcription. Each cDNA sample is labeled with its own 
specific dye. Reference cDNA is labeled with Cy5 (Red) while tumor cDNA is labeled 
with Cy3 (Green). Both cDNA samples are then washed over a single array, after which 
dye intensities on each spot is calculated using a fluorescence camera. 
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2.6 Functional Investigations 
2.6.1 Growth Kinetics 
Population doubling time was determined by seeding cells at an initial density of 1.5 
X 104 to 2.0 X 104 cells in 24 multi-well plates. A haemocytometer was used to count 
the cells daily in triplicates. The doubling time was ascertained from the logarithmic 
region of the growth curve. 
Briefly, cell count was conducted every 24hours using trypan blue for 7 consecutive 
days and the growth kinetic assay for each passage of an individual cell line was 
repeated in 3 independent experiments. The growth curves of HCC cells throughout 
7 days were plotted. Three different phases (including lag phase, log phase, 
stationary phase or death phase) for each cell lines over the 7-day period were 
displayed from the growth curve. 
Doubling time of the cells was then calculated based on the cell population's growth 
rate during exponential phase. The formula for doubling time is: 
Doubling Time (hours) = h*ln(2)/ln(c2/cl) 
h= duration of cell culture 
c l= total cell counted on previous day 
c2= total cell counted on current day 
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2.6.2 Cytotoxic Assay 
The cytotoxic effect of doxorubicin on the early passages and established cell lines 
was evaluated by the 3-[4, 5-dimethylthiazol-2-yl]-2, 5-diphenyltetrazolium bromide 
(MTT) assay. Cells from 9 pairs of HKCI series of HCC cells were seeded in 96-well 
culture plates at a density of 2000-4000 cells/well. 
After 24hours incubation, freshly prepared doxorubicin (Pharmaceutical Laboratories, 
Unterach, Austria) was delivered in sequential dilutions from 0 - 345 |iM. Five-
replicate wells were analyzed for each concentration. Incubation continued for 2 days, 
after which culture medium was aspirated and 200|il of MTT solution (0.1 mg/ml, 
Sigma) was added to each well. The reaction was stopped after 4 hours and the cell 
viability in each well was measured by the colorimetric product developed. 
The absorbance of colorimetric product was read at 570 nm in a Multilabel Plate 
Reader (Perkin Elmer Precisely). The MTT assays were repeated at least 3 times for 
each cell line. The survival factor was determined as IC50, which was defined as the 
concentration of cytotoxic drug causing 50% inhibition of cell growth, as compared 
to untreated control. 
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Chapter 3 - Results 
3.1 Molecular Cytogenetic Analysis 
3.1.1 Comparative Genomic Hybridization (CGH) 
3.1.1.1 Introduction 
Genetic aberrations including chromosomal gains, amplifications and loss of 
heterozygosity are hallmarks of cancer. The accumulation of these aberrations has 
fundamental roles in the development and progression of HCC, where changes in 
DNA copy number are believed to attribute to alterations of oncogene and tumor 
suppressor gene dosage (Kubota et al., 2001; Lengauer et aL, 1998; Barbashina et al., 
1995). 
The use of cell lines to identify aberrant chromosomal regions and tumor-associated 
genes is a common approach in contemporary cancer research. In this regard, it is 
important to understand how closely are primary tumors resembled in cell lines, 
especially in terms of the genomic aberrations present. 
In this study, 13 HKCI series of in-house established HCC cell lines were used as 
study models to evaluate the similarities between cell lines and their tumor of origin. 
CGH was performed with an aim to obtain an overview on the genomic pattern of 
each individual cell line at 3 different stages (Parental, Early Passage and Late 
Established Passage). The detail procedure involved was described in chapter 2.3. 
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3.1.1.2 CGH Results 
The CGH aberrations detected in the parental tumor, early and established passges of 
13 cell line groups examined have been tabulated in Table 3.1. From CGH analysis, 
each parental and cell line exhibited a number of regional chromosome gains and 
losses. In many instances, the cytogenetic abnormalities of individual tumor were 
inherited to its corresponding cell line. The CGH profile of early and established 
passages mostly mirrored the profile of the parental tumor. 
For example, HKCI-4 showed copy gain at Iql2-q24, 3ql3.3-q25, 5pl5.3-pl3, 
6p21.1-p25, 7, 8q22-q24.3, 12pl2-pl3, 12ql2-q24.1, 17q21-q25, 19，20, and Xq24-
q27 and losses were clustered at 4pl2-q35, and 13q32-q34 (Table 3.1). An amplified 
region was found to be located at I lql2-ql3. These chromosomal aberrations are the 
overlapping regions that were observed in the 3 different passages of HKCI-4. The 
partial CGH profile of the maintained regions such as -4pl2-q35, +8q22-q24.3 and 
+I lq l2 -q l3 amplification were shown in Figure 3.1. 
Nevertheless, few cell lines presented additional copy number changes after 
prolonged passages in-vitro (Figure 3.2). For instance, chromosome 13 and 
chromosome 18 in HKCI-2 and HKCI-6 respectively were found to be balanced in 
the parental tumor but deletion of the q-arm were detected in subsequent early and 
established passages. Chromosome 7 and chromosome 17 at different passages of 
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Cell Lines Parental Early Passage Established Passage 
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Figure 3.2: CGH profiles of representative chromosomes with novel aberrations 
and copy number shift throughout three different passages found in HKCI-2, 
HKCI-6 and HKCI-7. 
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3.1.1.3 Clustering Analysis of CGH Data 
In order to provide an unbiased overview on the similarities and differences in genomic 
imbalances between cell lines and their tumor of origin, 13 HKCI cell lines (early and 
established passages) and their corresponding parental HCC tumors were subjected to 
unsupervised two-way hierarchical clustering. 
To facilitate analysis, CGH interpretations on the 13 cell lines at 3 different stages were 
recoded as discrete numerics. The nomenclature adopted for each chromosome was 
according to the ISCN nomenclature. Regions rich in heterochromatin were excluded 
from analysis. The genomic alterations, i.e. copy number gains, copy number losses and 
balanced regions were recoded as 2, 0.5 and 1，respectively. Regional amplifications 
were denoted as 3.0. In this regard, CGH interpretation was assessed in a continuous 
manner across the remaining 322 cytobands that spanned the 24 chromosomes (22 
autosomes, and sex chromosomes X and Y). 
Cluster analysis showed distinct dendrograms that represent individual cell lines and 
tumor of origin (Figure 3.3). It is observed that 11 out of 13 cell lines (85%) were 
succesfully clustered into their respective family as indicated in red. Only two cell lines, 
HKCI-1 and HKCI-C2, failed to cluster together at all three different stages of the same 
cell line. The overall spectrum of copy number alterations of the early and established 
passages suggested close resemblence to its parental tumor at the genomic level. 
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Figure 3.3: Result obtained from unsupervised two-way hierarchical clustering 
shows that 11/13 (85%) cell lines (as indicated in red box) clustered under the 
same node, suggesting similar genomic changes. However, two cell lines, HKCI-1 
and HKCI-C2 as indicated in green box and blue box respectively were unable to be 
clustered into their respective family. 
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3.1.2 Spectral Karyotyping (SKY) 
3.1.2.1 Introduction 
Since CGH is unable to detect the ploidy status and balanced translocations, SKY 
analysis was performed to determine both structural and numerical aberrations of each 
cell line group. A total of 12 HKCI cell lines were examined for this part of the study, 
and details of the procedures are described in chapter 2.4. 
3.1.2.2 Ploidy Status 
SKY analysis revealed the ploidy number of cell lines to be generally maintained from 
the short-term cultured parental tumor, to the early passages and established cell line. 
The chromosome ploidy ranged mostly within diploidy to triploidy (Figure 3.4). 
The chromosome number and thus the ploidy status of HKCI-3, HKCI-8, HKCI-9, 
HKCI-C1 and HKCI-C3 were maintained throughout the in-vitro passaging. As for 
HKCI-2, HKCI-4, HKCI-6, HKCI-7 and HKCI-C2, a trend of chromosome number 
increment in the early passages was found and remained the same till established 
passages. 
The ploidy status of HKCI-1 was quite different among the other cell lines in which the 
chromosome number was maintained at near-diploid in both the parental and early 
passage but displayed drastic increment to tetraploid in established passage. Cytogenetic 
information on the parental tumor of HKCI-10 was not accessible due the inability to 
obtain metaphase chromosomes from the short-term culture. Nevertheless, a distinct 
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magnitude of chromosome number increase from near-triploid to pentaploid was 
observed in the early and established passages of HKCI-10 respectively. 
52 




























s P a r e n t a l 
• Early Passages 

























































































Figure 3.4: Ploidy status of 12 in i-house HCC cell lines at three different stages. 
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3.1.2.3 Structural Rearrangements 
From SKY analysis, many structural aberrations (including autosomes and sex 
chromosomes) were identified in the cell line passages and parental tumors. The number 
of translocations varied between individual cell line group, where some cell lines 
displayed less than five translocation events such as HKCI-6, HKCI-7, HKCI-C1 and 
HKCI-C3, while multiple chromosomal rearrangements of more than seven events could 
be found in HKCI-3, HKCI-4, HKCI-9 and HKCI-C2. Some translocation events 
detected in the parental samples were found to be maintained through propagation in cell 
lines, although some were gradually lost with time. Examples to highlight the 
maintained stem-line translocations and additional side-line rearrangements found in 3 
cell line groups, HKCI-9, HKCI-C1 and HKCI-C2 are shown in Figure 3.5 and 3.6a and 
Figure 3.7 respectively. 
A summary on the maintained stem-line translocations and translocations that have been 
lost with in-vitro passaging are shown in Figure 3.8a. The identification of stem-line 
aberrations that have been retained from the parental tumor may have implication for 
these rearrangements as important genetic events in the survival signal and clonal 
maintenance of the tumor. 
Other than stem-line aberrations, there were also additional translocations introduced at 
the early passages and were found to be maintained in the established cell line passage. 
These events may have a role in the in-vitro adaptations of HCC cells. A summary on 
these additional events are shown in Figure 3.8b. 
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HKCI-9 Parental Early Passages Established Passages 
Ploidy Near-triploid Near-triploid Near-triploid 
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Figure 3.5: Chromosomal rearrangements detected in HKCI-9. 
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Figure 3.5 demonstrates the chromosomal rearrangements detected in HKCI-9. A series 
of stem line aberrations were detected in this cell line, namely t(l;13), t(4;8), t(4; 19), 
t(5;9), t(7;13), t(8,17), t(12;20), t(4;12;16), t(17;19) and t(2;4). These stem-line 
aberrations were maintained throughout the in-vitro propagation except for t(17;19) 
which was detected in both parental and early passages and t(2;4) being consistently 
found in the parental tumor metaphases but eventually lost with time. The aberrations of 
t(l;9) and t(5;15) are side-line aberrations detected in early passages and these 
aberrations were maintained in established passages. Aberrations of r(4;12;16) was only 
found in early passages whereas t(l 1;12) and iso(13) were additional changes detected in 
the established passages. 
56 
Chapter 3 - Results 
HKCI-C1 Parental Early Passages Established Passages 
Ploidy Near-diploid Near-diploid Near-diploid 
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Figure 3.6a: Translocation events identified in HKCI-C1. 
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HKCI-C1 Parental Early Passage Established Passage 
a n m I I 
t(U;16) isoder(l 6)t(l 1; 16) 
Figure 3.6b: Additional aberration isoder(16)t(ll;16) resulted from evolutionary 
change. 
The partial spectral karyotype of cell line, HKCI-C1 is shown in figure 3.6a. Stem-line 
or maintained aberrations including der(ll)t(l;l 1), der(l)t(l;20), and der( 1 )t( 1; 19) were 
observed throughout the 3 stages, while der(16)t(l 1;16) only found in the parental stage 
and early passage. Besides, additional aberrations such as der(l l)t(l 1;19), der(21)t(4;21), 
der(22)t(16;22), der(5)t(5;19), and isoder(16)t(ll;16) were readily detected in the 
subsequent passages. Figure 3.6b is an example of evolutionary change resulted from in-
vitro adaptation. Derivative chromosome 16, t(ll;16) is suggested to be evolved from a 
single translocation event to an isochromosome of t(ll;6). 
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HKCI-C2 Parental Early Passages Established Passages 
Ploidy Near-triploid Near-tetraploid Near-tetraploid 
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• J t(7;13) 
: ^ T J j t(17;20) 
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Figure 3.7: Structural aberrations identified in HKCI-C2. 
An example of cell line with multiple chromosomal rearrangements is shown in HKCI-
C2 (Figure 3.7). The stem-line aberrations observed in this cell line comprises of t(X;l), 
t ( l ; l l ) , t(6;9), t(8;20), t(6;ll), t(17;22), t(3;12) and t(X;9). Besides, the number of side-
line aberrations that were identified in HKCI-C2 seems to be overwhelming. This 
category of aberrations that were introduced in the early passages and preserved till the 
established passages included t(l;4), t(7;l6), ins(8)t(8;l3;8), t(2;17;3;14), t(ll;17), 
t(3;7;l7;9), t(X;10), t(14;3;l7), t(3;7), t(3;10) and t(4;6). The number of additional 
abnormalities discovered in the established passage of this cell line is quite substantial 
and the involved translocation events are t(l;17), t(l;10), t(3;19), t(l;4), t(7;13), t(17;20), 
and t(4;22). 
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Figure 3.8b: An overview of additional or side-line aberrations at early and established 
passages of individual cell line. 
62 
Chapter 3 - Results 
3.1.2.4 Chromosomes Susceptible to Further Rearrangements 
Based on the analysis of structural rearrangements detected, chromosomes 1,7，11，and 
15 were some representative chromosomes that were prone to further in-vitro 
recombination as the average number of additional aberrations per cell line found in the 
early and established passages were overwhelming. They were found with frequent 
centromeric rearrangements and multiple euchromatic breakpoints. On the other hand, 
some chromosomes such as chromosome 6, 10, and 13 were found to be more stable 
with in-vitro culturing as the average number of aberrations decreased with time. Figure 
3.9 displays a summary on the average structural aberrations of 24 chromosomes per cell 
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3.1.2.5 Maintained Common HCC Translocations 
Although individual cell line exhibited a pattern of rearrangements, some of these cell 
lines do share common translocations with concurring breakpoints (Figure 3.10). For 
examples, translocation events of der(l)t(l;10) and der(19)t(17;19) are considered HCC-
related structural abnormalities that has been previously reported by our group (Pang et 
a1., 2002; Pang et al., 2000). It is interesting to note that these translocations have also 
been described in other cancer types, such as fibroblastic sarcoma and haemosiderotic 
fibrolipomatous tumour (Hallor et al., 2009). 
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3.2 Expression Profiling 
3.2.1 Introduction 
Gene expression profiling has provided novel insights into the molecular 
pathogenesis and classifications of human malignancies (Levy et al； 2002; Feitelson et 
al., 2002; Crawley and Furge 2002; Midorikawa et al., 2007). In this chapter, in order to 
measure how well each cell line captured the characteristic gene expression of the tumor 
it was derived from, a high-resolution cDNA microarray profiling was carried out on 8 
pairs of parental HCC tumors and their corresponding HKCI series of early passages. 
The technique of cDNA microarray was carried out as described in chapter 2.5. 
Representative images of array hybridization and scatter plot analysis for hybridizing 
quality are shown in Figure 3.11 and Figure 3.12. 
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Figure 3.11: Illustration of the representatives Cy3 and Cy5 superimposed cDNA 
mic roar ray images of one examined cell line, HKCI-C1. 
Each cDNA clone has been printed in duplicate on the microarray slide. Green spot (Cy3) 
indicates upregulation of gene transcript and red ones (Cy5) suggest down-regulation. Gene Pix 
Pro 3.0 was employed to analyze and quantify these raw images. 
• ••.' ' 
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Figure 3.12: A scatter plot of the microarray intensities of HKCI-C1. 
Each point on the graph corresponded to a feature on the array. Majority of the points fell 
along a line which extended at a 45° angle from the intersection of the X- and Y- axes, 
suggesting good hybridizing quality. 
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3.2.2 Gene Expression Profiling 
The expression profiles on parental tumors and cell lines were determined and the 
analysis of array results was carried out using web-available software (Cluster and 
Tree View). Before the clustering algorithm was applied, the fluorescence ratio for each 
spot was first log-transformed (log2); thereafter, the data was median-centered to remove 
experimental biases. By hierarchical clustering in an unsupervised manner, 8 pairs of 
HCC tumors and early culture passages were classified into two distinct dendrograms 
that coincided with the parental status and propagated cells (Figure 3.13). This finding 
suggested the transition from growth in-vivo to culture in-vitro involved adaptive gene 







































































































































































































































































































































































































































































Chapter 3 - Results 
3.2.3 The Ontologies of Deregulated Genes 
The microarray data sets were further analyzed by Significance Analysis of 
Microarrays (SAM) to determine the inducible candidate genes associated with the 
in-vitro culture adaptations. The expression profile of 8 pairs of parental HCC tumors 
and their corresponding early passages were subjected to a 70% filtration for the 
presence of transcript information. The underlying differential expressed genes 
between parental tumors and their early passages was further elucidated by SAM at a 
false discovery rate of <0.5%. 
SAM is a statistical technique to determine whether changes in gene expression of 
the test sample are statistically significant. SAM calculates a test statistic for relative 
difference in gene expression based on permutation analysis of expression data and 
calculates a false discovery rate. From SAM, a total of 744 significantly deregulated 
genes were defined. The numbers of up-regulated and down-regulated genes were 
322 and 422，respectively. To further characterize gene expression changes induced 
from in-vitro adaptation, the involved deregulated genes were analyzed by Database 
for Annotation, Visualization and Integrated Discovery (DAVID) 
(http://david.abcc.ncifcrf.gov/), a prospective and unbiased bioinformatics-based 
approach for functional ontologies. 
DAVID was employed to analyze the deregulated genes obtained from SAM. Gene 
symbols of significant deregulated genes were up-loaded onto the gene list and 
processed accordingly. The biological functions of genes generated provided a 
comprehensive set of functional annotation tools including Bio-Carta and KEGG 
pathway maps. 
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The pie chart shown in Figure 3.14 illustrates the functional ontologies that were 
found to be involved in the in-vitro adaptation of cultured cells. These included lipid 
metabolism (30%), biosynthesis of steroid (26%), and ubiquitination (15%). A small 
proportion of genes were found to be associated with adipocyte differentiation (11%), 
gluconeogenesis (11%) and glycolysis (7%). 
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Figure 3.14: Functional ontologies of SAM defined genes as analyzed by DAVID. 
The ontologies shown likely underline the in-vitro adaptations of cultured cells from 
primary tumor. 
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3.2.4 Maintained Biological Pathways 
The potential biological pathways that were maintained in both early culture 
passages and primary tumors were also investigated. Genes that were deregulated in 
both parental tumors and corresponding cell lines, either up-regulated or down-
regulated by 1.8-fold or more, were processed by Ingenuity Pathway Analysis (IPA) 
(http://www.iimenuitv.coni/). This web-based bioinformatic platform IPA is an all-
in-one software that can model, analyze, and define complex biological pathways by 
integrating gene expression information with signaling and metabolic pathways 
database. 
From the functional networks obtained via IPA, maintained genes were found with 
properties of cancer-related characteristics including "cellular growth and 
proliferation", "cell death" and "cancer cell cycle" (Table 3.2). Specific signaling 
pathways involved in the "cellular growth and proliferation" are TGF-beta and TNF-
alpha signaling. Few cancer-related genes participated in this functional network are 
CLU, VTN, DUSPl, MTIE, SERPINA5, and SERF INC L The involvement of 
Mapkinase pathway in the cell death functional network was found to be associated 
with MAP3K7IP1 and PTPRN that have important role in tumorigenesis. As for 
"cancer cell cycle", Cyclin D1 and TP53 were found to be the two main associated 
components. Down-regulated genes such as ATF5 and MTl family of genes were 
also observed in these pathways. Some of the maintained genes were also found to be 
involved in the regulation of "cell biological processes" and "immune response". 
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Associated , i ^ r^  , . , ^ Up-reeulated 
n • �� , Involved Down-regulated Genes ^ Rank Network „ j , , Genes ^ ” Pathway Involved , • , 
Functions Involved 
APOCL, APOC3, 
^ „ T . 1 ASGRl, BAAT，CHI3L1, 
Small Transcriptional 
1 Molecule f f f ^ ^ b y 肌’體乂SAA2， YPEL3 
Biochemistry HNF4A tD02’ TMEM176A, 
TTR 
AGT, C8B, CLU， 
… ， T � ， , DUSPl, ENQ FMOD, 
Cellulf , I f ' T u GC’ GSTM2, HSDl 7B6, 
2 Growth and TNF-alpha mTIE PLA2G2A 
Proliferation Signaling SERPINA5, SERPINCl, 
STARDIO, TGM2, VTN 
AGXT, GPX3, HLA- “ 
DPBl, IVD, KALRN, 
,…U 广 LEAP2, MAOB, FBLIML, 3 Cell Death MAPKmase MAP3K7IP1, MTIH, lAPP 
NSMCE2, PTPRN, 
RCORl 
ATF5, GLUDl, GSTM5, 
门 1, oc. AT r GTPBP4, HLA-DQAI, CBX3, 
4 Cancer Cell P53 and Cyclm 似 mTIB, MTIF, FKBP9 
Cycle RPLll，SLC2A4, NKIRAS2 
SUV39H1 
Cell-mediated CD81, CP, ECHSl, AKRIBI 
5 Immune HLA Mgnaimg ePB41, HLA-B, HLA-C, PABPCL 
Response 
Table 3.2: Functional networks and pathways obtained from IPA that was found to be 
maintained in primary tumors and their corresponding early passages. Higher ranking 
indicates higher number of genes involved in that particular functional network. 
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3.3 Functional Investigation 
3.3.1 Introduction 
In addition to the genomic and transcriptomic investigations, the HKCI series of cell 
lines were also studied for their changes in cell morphologies and functional 
behaviors, mainly growth kinetics and drug tolerance, with prolonged in-vitro 
propagations. Details of experimental procedures are described in Chapter 2.6. 
3.3.2 Cell Morphology 
The cell morphologies of 9 HKCI cell lines were captured at their early and 
established passages by an inverted microscope under lOOx magnifications. 
Images shown in figure 3.15 suggested cell morphologies between the early and 
established passages of each cell line to be largely similar. It would therefore suggest 
that the effect of prolonged in-vitro culture did not seem to confer much change 
towards cell morphology. 
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3.3.3 Growth Kinetics 
In-vitro cell culture at early stage has always been considered to have longer 
doubling time compared to the well-adapted late passages. In this study, HKCI series 
HCC cell lines were investigated for growth after multiple passaging. Cell count was 
performed continuously for 7 days in order to obtain a doubling time. Cell growth in 
culture can be modeled into four different phases including lag phase, exponential 
phase, stationary phase and decline phase (Figure 3.16). The cell counts at log phase 
of both early and established passages were calculated for their doubling time. An 
example of growth curves defined for HKCI-8 is shown in Figure 3.17. 
Based on the growth kinetic assay, the majority of established passages of cell lines 
indeed presented a shorter doubling time as compared to their early passages (Figure 
3.18). About 78% (7/9) of cell lines displayed more rapid growth kinetics after 
extended propagation including HKCI-1, HKCI-2, HKCI-3, HKCI-4, HKCI-5, 
HKCI-8 and HKCI-Cl and the percentage of decrement in doubling time for these 
cell lines ranged from approximately 10% to 36%. On the other hand, two cell lines 
namely HKCI-10 and HKCI-C2 showed reverse phenomenon in which the cells grew 
slower after extended propagation. The doubling time for HKCI-10 and HKCI-C2 
were increased by about 77% and 18% respectively in the established passages 
compared to early passages. 
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Figure 3.16: Phases that are involved in cell growth. 
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HKCI-8 (Early Passage) 
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Figure 3.17: Growth curves of HKCI-8 cells at early and established passages. 
The log phase obtained from both curves is indicated in red. The doubling times for 
the early and established passages are 29.89 hours and 26.68 hours respectively. 
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Figure 3.18: Doubling time of each cell line at early and established passages. 
The increase in proliferation rate of examined cell lines was not significant. This is 
probably because it was not a consistent event, as not all cell lines displayed shorter 
doubling time. 
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3.3.4 Cytotoxic Assay 
Cytotoxic response of the 9 pairs of HCC cell lines towards Doxorubicin at early and 
established passages was determined by the MTT assay. An example of dose 
response curve of HKCI-10 at early and established passages is shown in Figure 3.19. 
HKCI-1, HKCI-2, HKCI-3, HKCI-10, and HKCI-Cl demonstrated a substantial 
increase of IC50 in the established passages (Figure 3.20). It was found that the fold 
change of IC50 between the early and established passages for these cell lines was 
approximately 2-fold. Other cell lines, HKCI-4, HKCI-5 and HKCI-8, also presented 
higher IC50 in the established passages and the fold-change of IC50 was 
approximately 1.3-fold. The most profound case was HKCI-C2 which displayed 
about 3-fold increment of IC50 in the established passage compared to its early 
passage. 
It was found that the IC50 of established passages of all examined cell lines showed 
increased tolerance to the cytotoxic effect of doxorubicin relative to their 
corresponding early passages, with a significant p-value of 0.003 based on paired-t 
test. 
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Figure 3.19: Dose-response curve of both early and established passages of 
HKCI-10 obtained via MTT assay. 
The values of IC50 were indicated by red arrows. The difference in IC50 between the 
early and established passages is approximately 2-fold. 
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Figure 3.20: IC50 of Doxorubicin on early and established passages of HKCI cell 
lines. A significant p value of 0.003 was obtained from a paired-t test that has been 
performed on 9 pairs of cell lines based on their IC50 obtained through the cytotoxic 
effect of Doxorubicin assay. 
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Chapter 4 - Discussion 
4.1 Introduction 
Genetic abnormalities are hallmarks of many cancer types and most of these 
aberrations have been identified through investigations in established cancer cell 
lines. Although the contribution of cell lines in research field cannot be denied, the 
application of cancer cell lines as model system for tumors has been a subject of 
debate. To investigate the effect of prolonged in-vitro culture on the phenotypic 
changes of cancer cells, 13 in-house established HCC cell lines were studied. To 
examine whether these cultured cells resemble the properties of their tumor of origin, 
an integrative approach of molecular cytogenetic analysis, gene expression profiling 
and functional studies were carried out. 
4.2 Molecular Cytogenetic Analysis 
Based on CGH analysis, an overview on the genomic gains and losses was obtained, 
while SKY revealed information on both the ploidy status and chromosomal 
rearrangements in the HKCI series HCC cell lines. The combined platforms hence 
offered a comprehensive understanding on the cytogenetic changes between the 
primary parental tumors and the propagated early and established culture passages. 
Hierarchical clustering analysis of CGH data showed that most cell line groups 
clustered successfully into their respective family (11/13 cell lines; 85%) suggesting 
the majority of noticeable genetic abnormalities in the parental tumor was still well-
preserved after multiple passaging. Most maintained regional gains and losses were 
in concordance with the common HCC-related aberrations, such as +lq, +7q, +8q, 
+ 17p, +19q, +20q, -4q, -8p, -13q，and -16q (Guan et aL, 2000; Yumoto et al., 1995; 
Tamura et aL, 1997; Wong et al., 1999). These specific aberrations that contained in 
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each cell line suggested that there is an unstable genotype rather than a biological 
selection for a specific genetic gain and/or loss. 
From SKY analysis, the ploidy status of most cell lines were maintained with 
extended passaging (~3n), although few cell lines displayed an increased 
chromosome number in the early and established passages. Specifically, HKCI-1, 
HKCI-2, and HKCI-10 showed more overwhelming chromosome number increment 
(from 3n to 5n) in early and/or established passages than other cell lines. A possible 
reason for this phenomenon could be the interruption of genes responsible for the 
chromosomal instability already existed as part of genetic aberrations in the parental 
tumor. With prolonged in-vitro propagation, these genes could further promote 
recombinations or DNA double-strand breaks during the process of chromosomal 
segregations leading to the formation of added numerical and structural 
abnormalities. Defects in the gatekeeper genes such as RanBP2, T0P02A, and 
Aurora-A have been shown to allow cells with abnormal DNA changes to divide 
continuously in the cell culture resulting in further aneuploidy and induce 
chromosomal instability (Kolodner et al., 2002; Nasmyth K. 2002). 
RanBP2 is a GTP-binding protein with SUMO E3 ligase activity that functions in 
conjunction with T0P02A in ensuring proper decatenation of sister chromatids and 
prevention of anaphase bridge formation during mitosis (Dawlaty et al., 2008). 
Aurora-A, on the other hand, is responsible for mitotic-spindle checkpoints and has 
been reported to be commonly over-expressed in HCC tumour (Jeng YM et al., 
2004). Further investigations will be required to establish the expressions of RanBP2, 
T0P02A and Aurora-A in the HKCI cell line groups. 
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Although changes in chromosome copy number, and thus the ploidy status, did not 
differ much with in-vitro culturing in most cell lines, the presence of additional 
structural aberrations in early and established passages could readily be observed in 
almost all cell lines through SKY analysis. This phenomenon has also been reported 
in human glioma cell lines (Li et al., 2008). For example, it was found that 
chromosomes such as chr.3 chr.5 and chr. 15 exhibited a few or none chromosomal 
translocations in the parental tumors, but the presence of rearrangements were 
detected in a number of propagated cell lines (Figure 3.9). It is plausible that 
structural rearrangements which provide advantageous mutations in the tumor but 
difficult to persist in in-vivo tumor microenvironment might be able to recuperate the 
aberrations and expand greatly in in-vitro environment. 
Additional aberration can also occur from terminal deletions due to a break of a 
single chromatid giving rise to a centric derivate chromosome plus an acentric 
fragment. This could be resultant from centromeric hypomethylation, which is often 
found in solid tumours including HCC (Nagai et al., 1999, Saito et al., 2002). The 
acentric fragment which failed to bind the mitotic spindle will be permanently lost in 
the subsequent cell division, and may be seen as a lagging chromatin body at 
metaphase or anaphase. The evidence of such events is commonly observed in the 
cell population of tumors including HCC, head and neck and breast carcinomas 
(Natarajan et al., 1996; Steinbeck, 1997). 
It has been proposed that a continuous accumulation of chromosome changes in a 
cell population may thus arise either through an elevated mutation frequency, a 
decreased tendency of self-elimination among mutated cells, or both and it can be 
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further complicated by the influence of environmental factors on experimental 
systems (Johansson and Mertens, 1986). 
In each cell line, karyotypic rearrangements were also found to be retained after 
subsequent passages. These stem-line aberrations likely held importance in the clonal 
expansion and survival advantages of transformed malignant hepatocytes, and thus 
provide significant implications in the liver tumorigenesis. Several common HCC-
related aberrations with specific regional breakpoints were found to be maintained in 
the HKCI cell lines. For example, breakpoints chr.lpl3-q21, chr.8pl2-q21, 
chr.l7pll-ql2, chr.l7q22 and chr. 19pl0-q 13.1 are well preserved in the propagated 
cells. 
Additional side-line aberrations found, on the other hands, are often regarded as 
culture artifacts and not genuine events responsible for cancer progression. Based on 
the molecular cytogenetic characterizations carried out here, it is reckoned that 
studies on chromosomal regions or translocations which are less susceptible to 
additional aberrations will have more impact on understanding the HCC 
tumorigenesis as properties of their tumor of origin are well-conserved after multiple 
passaging. 
Regarding the growth kinetics of examined cell lines as shown in Figure 3.18, it was 
found that majority of cell lines possessed shorter doubling time after subjected to 
extended propagation. However, HKCI-10 and HKCI-C2 were found to have 
increased doubling time in the established passages as compared to their 
corresponding early passages. This phenomenon could be in part due to an increased 
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ploidy number. For instance, HKCI-10 has a larger number of chromosomes 
(ploidy=5n) which might serve as a burden for the cell to carry out basic functions 
and metabolisms at a normal rate during each cell division cycle. On the other hand, 
few cell lines such as HKCI-1, HKCI-2, and HKCI-6 have shorter doubling time 
with the increased ploidy number. One possibility for this event is that the change in 
ploidy might alter the number of copies or particular genes which responsible for the 
control of proliferation. It has been reported that the expressions of several genes 
were down-regulated with increase ploidy number based on a microarray analysis of 
yeast strains with different ploidy (Galitski T. et aL, 1999). Some cell lines with 
maintained ploidy number at three different stages were able to proliferate at a higher 
speed probably because the additional aberrations being introduced in the subsequent 
passages have influenced the gene expression of these cell lines, and thus increased 
the proliferation rate of the well-adapted cells that have gone through multiple 
passaging. 
4.3 Expression Profiling 
Other than chromosomal analysis, the expression of genes at transciptomic level was 
elucidated by cDNA microarray. From the gene expression profiling of 8 pairs of 
HKCI cell lines, a distinct difference of gene expression between the parental tumor 
and corresponding cell lines was observed. The outcome of unsupervised hierarchical 
clustering suggested that the cell lines share an underlying molecular feature more 
closely related to their in-vitro culture condition rather than to their corresponding 
primary tumors. Both the genetics of the selected clone and the epigenetics of the 
selective environment contributed to tumor development (Chow M and Rubin H.， 
2000). Under the influence of clonal selection for optimal cell growth in-vitro and 
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clonal expansion (Rajagopalan et al., 2003; Li et al., 2000), these circumstances 
could have brought about aneuploidy and alteration in gene expression. 
For instance, in-vitro cell cultures were basically fed with complex nutrient such as 
fetal calf serum (FBS), growth medium and also insulin-transferrin-selenium (ITS) in 
order to mimic the in-vivo environment. Culture medium is rich in soluble factors, 
cytokines, growth factors and other components as well as lack of three-dimensional 
tumor-stromal interactions, thus it might cause changes in gene expression to adapt 
better under the estranged endogenous or exogenous force (Hodkinson et al., 2007). 
The components contained in culture medium could have conferred changes to the 
cell physiology via the alteration of certain metabolic pathways. 
In the cellular adaptation in-vitro, functional ontologies obtained from DAVID 
suggested deregulated genes are mostly involved in the lipid metabolism, 
biosynthesis of steroid, ubiquitination, and glycolysis. It has been reported that tumor 
cells feeding on culture medium may secrete certain cytokines and growth factors 
that may lead to the production of protective extracellular matrix (ECM) proteins. 
The ECM proteins orchestrated by several metabolic pathways can influence the 
physiological processes and cells physical properties such as mechanical stiffness 
(Jain R.K. 1998). A previous study has suggested that the up-regulation of ABC 
transporters, including P-gp which encoded by MDRl gene may potentially lead to 
cellular chemoresistance towards doxorubicin. It is suggested that the over-
expression of P-gp could induce drug-resistance of the cells through an increasing 
the cellular drug efflux from the binding of drug molecules to P-gp within the lipid 
bilayer cell membrane (Pang E. et al., 2005). 
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Differentially expressed genes such as GNGll, C0L6A1, SNX4, SNX17, and PFKM 
that involved in lipid metabolism and glycolysis can be triggered by intrinsic tumor 
properties or by environmental stress factors. As a result, the sensitivity of cells 
towards drug-induced apoptosis can be affected (Kraus A.C. et al, 2002; Kouniavsky 
G. et al” 2002; Maubant S. et al, 2002; Sethi T. et al, 1999; Weaver V.M. et al., 
2002; Lotem J. et al, 1991). In line with the finding of a higher IC50 towards 
Doxorubicin with in-vitro passaging, it is plausible that a progressive dominance of 
these deregulated metabolic pathways underline the increasing drug tolerance found. 
Through IPA, a high proportion of maintained genes expression was found to be 
associated with cancer functional networks including cellular growth and 
proliferation, cancer cell cycle and cell death. Some remarkable pathways which 
have important implications in human cancers such as TNF-alpha, MAPKinase and 
Cyclin D1 were also found to be involved in these networks. Several cancer-related 
genes such as CLU, DUSPl, VTN, PTPRN, ATF5, MTl family and SERPIN family 
were identified in these biological pathways, and showed high concordance in 
expressions between the parental tumor and cell line. Earlier study from our group on 
ATF5 demonstrated common repression of this transcription factor in HCC tumours 
and a functional role in the control of cell cycle progression at the G2-M phase (Gho 
et al., 2008). The tumor suppressive role of ATF5 was further shown to be associated 
with MAPKinase signaling. 
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4.4 Conclusion 
On the whole, the outcome of this project shows that HKCI series HCC cell lines are 
reliable instruments as in-vitro experimental models as these established cell lines 
highly resembled the cancerous properties of their corresponding tumor of origin. A 
number of stem-line aberrations and important cancer-related genes and signaling 
pathways of the primary tumors were found to be maintained in the prolonged in-
vitro propagation. 
Nevertheless, the usage of earlier passages of tumor-derived cell culture would 
undoubtedly provide a more reliable resource for research purposes regardless of 
genomic or transcriptomic investigation is to be performed. This is because low-
passage cell cultures bear a higher resemblance to the primary tumors from which 
they were originally derived. The issue of sideline aberrations introduced during the 
cultivation of the cell lines is also a concern in research studies. 
Therefore, investigations and explorations of genomic mapping of cultured cells 
should accompanied with certain form of preventive and precautious measures such 
as identifying between the culture artifacts and true events of cancer at the initial 
stage of research to avoid the underlying pitfalls of cell lines that might prevent us 
from achieving our research goals. From the results found in this thesis, it would be 
suggestive that keeping the number of passages within a confined threshold of 25-30 
during the cultivation of cell lines and simultaneously achieving a more homogenous 
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